Ronald T. Riley

Overview

Best Publications

• Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme.

  E Wang;W P Norred;C W Bacon;R T Riley

  1435
  Citations

• IARC Monographs on the evaluation of carcinogenic risks to humans: Some traditional herbal medicines, some mycotoxins, naphthalene and styrene

  Ahti Anttila;Ramesh V. Bhat;James A. Bond;Susan J. Borghoff

  1230
  Citations

• Sphingolipids - The enigmatic lipid class: Biochemistry, physiology and pathophysiology

  Merrill Ah;Schmelz Em;Dillehay Dl;Spiegel S

  820
  Citations

• Fumonisins Disrupt Sphingolipid Metabolism, Folate Transport, and Neural Tube Development in Embryo Culture and In Vivo: A Potential Risk Factor for Human Neural Tube Defects among Populations Consuming Fumonisin-Contaminated Maize

  Walter F O Marasas;Ronald T. Riley;Katherine A. Hendricks;Victoria L. Stevens

  804
  Citations

• Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins.

  A H Merrill;M C Sullards;E Wang;K A Voss

  507
  Citations

• Alteration of Tissue and Serum Sphinganine to Sphingosine Ratio: An Early Biomarker of Exposure to Fumonisin-Containing Feeds in Pigs

  Ronald T. Riley;Nyeon Hyoung An;Jency L. Showker;Hwan Soo Yoo

  379
  Citations

• Fumonisin- and AAL-Toxin-Induced Disruption of Sphingolipid Metabolism with Accumulation of Free Sphingoid Bases

  H. K. Abbas;T. Tanaka;S. O. Duke;J. K. Porter

  362
  Citations

• Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.

  Ronald T. Riley;Evaristus Enongene;Kenneth A. Voss;William P. Norred

  318
  Citations

• Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals.

  Nicholas C. Zitomer;Trevor Mitchell;Kenneth A. Voss;Genevieve S. Bondy

  311
  Citations

• Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme.

  Elaine Wang;P. Frank Ross;Terrance M. Wilson;Ronald T. Riley

  311
  Citations

• Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells.

  Hwan-Soo Yoo;William P. Norred;Elaine Wang;Alfred H. Merrill

  282
  Citations

• Cyclopiazonic acid inhibition of the Ca2+-transport ATPase in rat skeletal muscle sarcoplasmic reticulum vesicles.

  Douglas E. Goeger;Ronald T. Riley;Joe W. Dorner;Richard J. Cole

  279
  Citations

• Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity.

  Ronald T. Riley;Dorothy M. Hinton;William J. Chamberlain;Charles W. Bacon

  271
  Citations

• Maternal fumonisin exposure and risk for neural tube defects: Mechanisms in an in vivo mouse model

  Janee Gelineau-Van Waes;Lois Starr;Joyce Maddox;Francisco Aleman

  260
  Citations

• An historical overview of field disease outbreaks known or suspected to be caused by consumption of feeds contaminated with Fusarium toxins

  D.P. Morgavi;R.T. Riley

  232
  Citations

• An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme.

  Kenneth A. Voss;Ronald T. Riley;W. P. Norred;Charles W. Bacon

  218
  Citations

• Liquid chromatographic determination of sphinganine and sphingosine : use of the free sphinganine-to-sphingosine ratio as a biomarker for consumption of fumonisins

  Ronald T Riley;Elaine Wang;Alfred H Merrill

  197
  Citations

• Elevated Sphingoid Bases and Complex Sphingolipid Depletion as Contributing Factors in Fumonisin-Induced Cytotoxicity

  Hwan-Soo Yoo;William P. Norred;Jency Showker;Ronald T. Riley

  181
  Citations

• Transformation-mediated complementation of a FUM gene cluster deletion in Fusarium verticillioides restores both fumonisin production and pathogenicity on maize seedlings.

  Anthony E. Glenn;Nicholas C. Zitomer;Anne Marie Zimeri;Lonnie D. Williams

  169
  Citations

• Implications of Apoptosis for Toxicity, Carcinogenicity, and Risk Assessment: Fumonisin B1 as an Example

  Yvonne P. Dragan;Wayne R. Bidlack;Samuel Monroe Cohen;Thomas L. Goldsworthy

  168
  Citations